Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts

Area of Science:

• Cardiology
• Cell Biology
• Pharmacology

Background:

• Doxorubicin (DOX) is an effective anti-cancer drug but causes significant cardiotoxicity, particularly delayed and persistent effects seen years after treatment.
• Childhood cancer survivors treated with DOX are at risk for late-onset cardiac failure, with mechanisms of this persistent toxicity remaining unclear.
• DOX-induced removal of cardiac progenitor cells and potential differential toxicity to undifferentiated muscle cells may contribute to impaired cardiac development and long-term damage.

Purpose of the Study:

• To investigate the differential cytotoxicity of doxorubicin (DOX) in H9c2 myoblasts at various differentiation stages.
• To elucidate the mechanisms underlying DOX-induced cardiotoxicity by examining cellular responses in differentiated versus undifferentiated muscle cells.
• To understand the role of cell differentiation in modulating susceptibility to anthracycline-induced cardiotoxicity.

Main Methods:

• Utilized H9c2 myoblasts, a rat embryonic cell line capable of differentiating into skeletal or cardiac muscle phenotypes.
• Assessed DOX accumulation and cytotoxicity in H9c2 cells across different differentiation states.
• Measured cell proliferation, differentiated muscle marker expression, mitochondrial superoxide dismutase levels, Bcl-xL protein expression, and p53 activation.

Main Results:

• H9c2 cell differentiation led to decreased proliferation and increased expression of differentiated muscle markers.
• Differentiated H9c2 cells exhibited higher DOX accumulation and were more susceptible to DOX-induced cytotoxicity compared to undifferentiated cells.
• While differentiated cells showed increased mitochondrial superoxide dismutase and Bcl-xL, p53 activation was similar across differentiation states, suggesting complex stress responses.

Conclusions:

• Contrary to expectations based on increased protective mechanisms, differentiated H9c2 muscle cells are more vulnerable to DOX-induced cardiotoxicity.
• These findings highlight that differentiated muscle cells, not just progenitor cells, are key targets in DOX cardiotoxicity.
• The study provides critical insights into the stress responses of H9c2 cells at different differentiation stages, aiding the understanding of anthracycline cardiotoxicity mechanisms.